Oribiotech

PITCH

Ori Biotech is a London- and Philadelphia-based innovator in CGT manufacturing that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalised, lifesaving treatments. By fully automating and standardising CGT manufacturing in a closed platform, Ori offers therapeutics developers the opportunity to seamlessly scale from pre-clinical process development to commercial scale manufacturing. So complex manufacturing challenges can be put where they belong – in the past.

Based in

London

Created in

> Website

LATEST INVESTMENT

#Healthtech 10.2020

Oribiotech

£27.7M

Northpond Ventures, Octopus Ventures, Amadeus Capital Partners, Delin Ventures and Kindred Capital.